ADMET Conference
 

Exploring the optimisation of ADMET modelling techniques, preclinical DMPK applications and development of biopharmaceuticals

SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018, featuring.

Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times.

The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

*Source: http://bit.ly/2hMJcgU

Join our expert speaker panels at the ADMET conference to ensure you do not miss out on the latest developments!

Presenting new technologies, specific case studies and PK modelling strategies in the areas of DMPK, PBPK, PKPD, in vitro / ex vivo / in vivo / in silico, biologics, transporters, hazard and safety assessments, ADMET modelling, and many more.

This event is CPD accredited.

BENEFITS OF ATTENDING:
The ADMET conference will cover new developments in all areas of the ADMET sector, from the evaluation of novel PBPK modelling softwares to the validation of humanised mice models.

Join us this year in July to hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:

ADME/PK Optimisation for Drug Design and Discovery 
Physiochemical Assessments
Drug Screening Technology 
In Vitro to Human In Vivo Translation 
Physiologically Based PK Modeling 
DMPK, PBPK, PKPD 
Pre-/Clinical Toxicity 
Biologics
Accurate First-in-Human Dose Predictions 
Transporters, Bioavailability, Formulation 
Drug Delivery 
Metabolism Studies
Drug-Drug Interactions 
In vivo / in vitro / in silico 
Hazard and Safety Assessment 
Predictive Toxicology 
Preclinical Pharmacology Testing 

CHAIR: Eric Bloome, Vice President, Global Pre-Clinical Safety Senior Research Fellow, AbbVie

FEATURED SPEAKERS:

Pau Aceves, Associate Director, Certara Strategic Consulting
Peter Littlewood, Director DMPK, Vertex Pharmaceuticals
Filipe Lopes, Laboratory Head, DMPK, Roche
Andreas Reichel, VP, Head of Research Pharmacokinetics, Bayer Ag
Laurent Salphati, Principal Scientist, Genentech
Timothy Schulz-Utermoehl, Director of DMPK & Physical Sciences, Sygnature Discovery
Kunal Taskar, Senior DMPK Investigator, GSK
Robert Van Waterschoot, Head of Pharmacokinetics, Dynamics & Metabolism PDM Leaders, Roche Pharmaceuticals
Ian Wilson, Professor, Drug Metabolism & Molecular Toxicology, Imperial College London

KEY REASONS TO ATTEND:
The conference will cover new developments in all areas of the ADMET sector, from the evaluation of novel PBPK modelling software’s to the validation of humanised mice models.

Join us this year in July to hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:      

ADME/PK Optimisation for Drug Design and Discovery
Physiochemical Assessments

In Vitro to Human In Vivo Translation

Physiologically Based PK Modeling
        
DMPK, PBPK, PKPD

Pre-/Clinical Toxicity

Biopharmaceuticals

Accurate First-in-Human Dose Predictions

Transporters, Bioavailability, Formulation

Drug Delivery

Metabolism Studies

Drug-Drug Interactions

In vivo / in vitro / in silico

Hazard and Safety Assessment

Predictive Toxicology
Pre-clinical Pharmacology Testing 

WHO SHOULD ATTEND:         

DMPK Professionals        
Pharmacologists
       
Computational Scientists

Medicinal Chemists
   
Statisticians
  
Principle scientist

Drug Metabolism Experts

ADME Toxicologists
   
Research fellows
        
PK/PD modelling

Toxicologist

Anatomists

EARLY BIRD-RATES
BOOK BY 30TH APRIL AND SAVE �200
BOOK BY 31ST MAY AND SAVE �100

Related Events

Comments